KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Net Income towards Common Stockholders (2016 - 2026)

Johnson & Johnson's Net Income towards Common Stockholders history spans 17 years, with the latest figure at $5.2 billion for Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders fell 52.4% to $5.2 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $21.0 billion, a 91.29% increase, with the full-year FY2023 number at $21.8 billion, up 1289.37% from a year prior.
  • Net Income towards Common Stockholders hit $5.2 billion in Q1 2026 for Johnson & Johnson, up from $5.1 billion in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for JNJ hit a ceiling of $21.7 billion in Q4 2023 and a floor of -$232.0 million in Q3 2023.
  • Historically, Net Income towards Common Stockholders has averaged $4.3 billion across 4 years, with a median of $578.0 million in 2022.
  • The widest YoY moves for Net Income towards Common Stockholders: up 14575.0% in 2023, down 142.03% in 2023.
  • Tracing JNJ's Net Income towards Common Stockholders over 4 years: stood at $148.0 million in 2022, then tumbled by 156.08% to -$83.0 million in 2023, then surged by 6263.86% to $5.1 billion in 2025, then increased by 2.33% to $5.2 billion in 2026.
  • Business Quant data shows Net Income towards Common Stockholders for JNJ at $5.2 billion in Q1 2026, $5.1 billion in Q4 2025, and $5.2 billion in Q3 2025.